Geron Corp. (GERN) and GE Healthcare, a unit of General Electric Co. (GE), announced Tuesday morning that they entered into a global exclusive license and alliance agreement to develop and commercialize cellular assay products derived from human embryonic stem cells for use in drug discovery, development and toxicity screening.
Geron Corp. gapped up sharply Tuesday and has continued to rise gradually on the highest volume in over a month. The stock is now challenging resistance at the highs of the year, trading at nearly a 5-month high.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.